デフォルト表紙
市場調査レポート
商品コード
1498731

魚類ワクチン市場：ワクチンタイプ別、適応症別、投与経路別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測

Fish Vaccines Market, By Vaccine Type, By Indication, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 316 Pages
納期
2～3営業日
カスタマイズ可能
魚類ワクチン市場：ワクチンタイプ別、適応症別、投与経路別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 316 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

レポートハイライト

魚類ワクチンの市場規模は2023年に3億8,240万米ドルとなり、2024～2032年にかけてCAGR 7.40%で拡大

魚類ワクチン市場-市場力学

養殖活動の増加が魚類ワクチン市場の成長を促進

養殖活動の急増が魚類ワクチン市場の成長を大きく促進しています。国連食糧農業機関（FAO）によると、世界の養殖生産量は着実に増加しており、2030年には1億900万トンに達すると予測されています。この拡大には、タンパク質源としての魚に対する需要の高まりが拍車をかけており、サステイナブル収量を確保するために効果的な健康管理が必要となっています。例えば、サケ養殖の先進国であるノルウェーでは、伝染性サケ貧血や魚類オルソレオウイルスなどの疾病と闘うために魚類ワクチンが大幅に採用され、生産効率が向上しています。このような動向は、魚の健康を維持し、水産養殖産業の繁栄を支えるワクチンの重要な役割を浮き彫りにしています。

魚類ワクチン市場-主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024～2032年）に約7.40%のCAGRで毎年成長すると予測されています。

ワクチンのタイプ別セグメンテーションによると、2023年には弱毒ワクチンが最大の市場シェアを示すと予測されています。

適応症別では、2023年にせつ腫症が主要なタイプとなっています。

投与経路別では、経口が2023年の主要タイプでした。

地域別では、2023年に欧州が主要な収益源となった

魚類ワクチン市場-セグメンテーション分析：

フィッシュワクチンの世界市場は、ワクチンタイプ、適応症、投与経路、エンドユーザー、地域に基づいてセグメント化されます。

市場はワクチンタイプに基づいて7つのカテゴリーに分けられます：死菌ワクチン、不活化ワクチン、弱毒化ワクチン、トキソイドワクチン、サブユニットワクチン、結合ワクチン、組み換えベクターワクチンです。魚類ワクチン市場をリードするのは、強力で長期間持続する免疫反応を誘導する効果がある不活化ワクチンです。不活化ワクチンが安全性と安定性を提供します。死菌ワクチン、サブユニットワクチン、トキソイドワクチンは特定のニーズに応えるものであり、結合ワクチンや組み換えベクターワクチンは高度な免疫化技術を持つ新興セグメントです。

市場は適応症別に4つのカテゴリーに分類される：せつ腫症、ビブリオ症、エルシニア症、腸管敗血症です。せつ腫症は広く蔓延し、サケ科魚類に大きな影響を与えるため、フィッシュワクチン市場を独占しています。ビブリオ症がこれに続き、世界的に様々な魚種に影響を及ぼしています。エルシニア症と腸性敗血症も、養殖における特定の細菌感染を対象として、かなりの市場シェアを占めています。

魚類ワクチン市場-地理的洞察

欧州、特にノルウェーやスコットランドのような国々は、先進的な水産養殖産業と魚類ワクチン接種の高い採用率により、市場をリードしています。北米、特に米国とカナダもまた、大規模なサケとマスの養殖によって大きな市場成長を示しています。アジア太平洋では、中国、インド、ベトナムなどの国々が、養殖生産の増加と魚の健康管理に対する意識の高まりにより、急速な市場拡大を経験しています。ラテンアメリカと中東・アフリカは新興市場であり、養殖インフラへの投資拡大とサステイナブル養殖方法を推進する政府の取り組みに支えられています。

魚類ワクチン市場-競合情勢：

Zoetis Inc.、Merck &Co., Inc.（子会社のMSD Animal Healthを通じて）、Elanco Animal Health、HIPRAなどの大手企業は、さまざまな魚の病気を対象にしたワクチンの多様なポートフォリオを提供することで、市場を独占しています。これらの企業は、より効果的な新ワクチンの導入、ワクチン送達方法の改善、戦略的提携や買収による地理的範囲の拡大など、研究開発に注力しています。例えば、ZoetisによるFish Vet Groupの買収は、診断能力とワクチンの提供を強化することで、市場での地位を強化しました。さらに、ワクチン技術を進歩させ、新たな魚病への対処を目指す企業と学術機関の連携も盛んです。例えば、2023年3月、Indian Immunologicals（IIL）は、淡水魚の出血性敗血症に対するワクチンの商業的開発のため、Central Institute of Freshwater Aquaculture（CIFA）と提携しました。さらに、地域の中小企業も、地域の特定のニーズや規制要件に対応することで市場に貢献しています。

目次

第1章 魚類ワクチン市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブ概要

  • 市場内訳
  • 競合考察

第3章 魚類ワクチンの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 魚類ワクチン産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 魚類ワクチン市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 魚類ワクチン市場情勢

  • 魚ワクチン市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 魚類ワクチン市場-ワクチンタイプ別

  • 概要
    • ワクチンタイプ別セグメントシェア分析
    • 死菌ワクチン
    • 不活化ワクチン
    • 弱毒化ワクチン
    • トキソイドワクチン
    • サブユニットワクチン
    • 結合ワクチン
    • 組み換えベクターワクチン

第8章 魚類ワクチン市場-適応症別

  • 概要
    • 適応症別セグメントシェア分析
    • せつ腫症
    • ビブリオ症
    • エルシニア症
    • 腸管敗血症
    • その他

第9章 魚類ワクチン市場-投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 注射
    • 薬浴
    • 噴射
    • 経口

第10章 魚類ワクチン市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 養殖場
    • 孵化場
    • 研究機関

第11章 魚類ワクチン市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析-魚類ワクチン業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Aleph Farms
    • BioMar Group
    • Ceva Sante Animale
    • Elanco Animal Health（Eli Lilly and Companyの一部）
    • Fish Vet Group（Benchmark Holdings plcの一部）
    • HIPRA
    • Hipra Animal Health Limited
    • Intervet Inc.（Merck &Co., Inc.の一部）
    • Merck Animal Health（Merck &Co., Inc.の一部）
    • MSD Animal Health（Merck &Co., Inc.の一部）
    • Nisseiken Co., Ltd.
    • Syndel Laboratories
    • Vaxxinova
    • Vetech Laboratories
    • Vetoquinol SA
    • Zoetis Inc.
    • その他

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Fish Vaccines Market: Vaccine Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
  • TABLE Global Fish Vaccines Market, by Vaccine Type 2019-2032 (USD Million)
  • TABLE Fish Vaccines Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Fish Vaccines Market, by Indication 2019-2032 (USD Million)
  • TABLE Fish Vaccines Market: Route of Administration Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Fish Vaccines Market, by Route of Administration 2019-2032 (USD Million)
  • TABLE Fish Vaccines Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Fish Vaccines Market, by End-User 2019-2032 (USD Million)
  • TABLE Fish Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Fish Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE North America Fish Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Europe Fish Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Fish Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Fish Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Fish Vaccines Market, by End-User, 2019-2032 (USD Million)
目次
Product Code: ANV2900

REPORT HIGHLIGHT

Fish Vaccines Market size was valued at USD 382.40 million in 2023, expanding at a CAGR of 7.40% from 2024 to 2032.

The Fish Vaccines Market involves the development and distribution of vaccines aimed at preventing diseases in fish populations, crucial for aquaculture health management. The increasing demand for fish protein, rising aquaculture practices, and advancements in vaccine technologies are growth factors in the market. Additionally, growing awareness about sustainable aquaculture and the need to reduce antibiotic usage in fish farming further bolsters the market. However, challenges such as high vaccine development costs, regulatory hurdles, and limited access to vaccines in developing regions restrain growth. Opportunities lie in the expansion of aquaculture in emerging markets, innovation in vaccine delivery methods, and government initiatives promoting sustainable fish farming practices.

Fish Vaccines Market- Market Dynamics

Rising Aquaculture Activities Propel Growth in the Fish Vaccines Market

The surge in aquaculture activities is significantly driving the growth of the Fish Vaccines Market. According to the Food and Agriculture Organization (FAO), global aquaculture production has been steadily increasing and is projected to reach 109 million tonnes in 2030. This expansion is fueled by the growing demand for fish as a protein source, necessitating effective health management practices to ensure sustainable yields. For instance, Norway, a leading country in salmon farming, has seen substantial adoption of fish vaccines to combat diseases like infectious salmon anemia and piscine orthoreovirus, enhancing production efficiency. Such trends highlight the crucial role of vaccines in maintaining fish health and supporting the thriving aquaculture industry.

Fish Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.40% over the forecast period (2024-2032)

Based on Vaccine Type segmentation, Attenuated Vaccine was predicted to show maximum market share in the year 2023

Based on Indication segmentation, Furunculosis was the leading type in 2023

Based on Route of Administration segmentation, Oral was the leading type in 2023

On the basis of region, Europe was the leading revenue generator in 2023

Fish Vaccines Market- Segmentation Analysis:

The Global Fish Vaccines Market is segmented on the basis of Vaccine Type, Indication, Route of Administration, End-User, and Region.

The market is divided into seven categories based on Vaccine Type: Killed Vaccine, Inactivated Vaccine, Attenuated Vaccine, Toxoid Vaccine, Subunit Vaccine, Conjugate Vaccine, and Recombinant Vector Vaccines. Attenuated vaccines lead the Fish Vaccines Market due to their effectiveness in inducing strong and long-lasting immune responses. Inactivated vaccines follow, offering safety and stability. Killed vaccines, subunit vaccines, and toxoid vaccines cater to specific needs, while conjugate and recombinant vector vaccines represent emerging segments with advanced immunization techniques.

The market is divided into four categories based on Indication: Furunculosis, Vibriosis, Yersiniosis, and Enteric septicaemia. Furunculosis dominates the Fish Vaccines Market due to its widespread prevalence and significant impact on salmonids. Vibriosis follows, affecting various fish species globally. Yersiniosis and enteric septicaemia also hold substantial market shares, targeting specific bacterial infections in aquaculture.

Fish Vaccines Market- Geographical Insights

Europe leads the market, particularly countries like Norway and Scotland, due to their advanced aquaculture industries and high adoption of fish vaccination practices. North America, notably the United States and Canada, also shows significant market growth driven by extensive salmon and trout farming. In the Asia-Pacific region, countries such as China, India, and Vietnam are experiencing rapid market expansion due to increasing aquaculture production and rising awareness about fish health management. Latin America and the Middle East & Africa are emerging markets, supported by growing investments in aquaculture infrastructure and government initiatives promoting sustainable fish farming practices.

Fish Vaccines Market- Competitive Landscape:

Leading companies such as Zoetis Inc., Merck & Co., Inc. (through its subsidiary MSD Animal Health), Elanco Animal Health, and HIPRA dominate the market by offering a diverse portfolio of vaccines targeting various fish diseases. These companies focus on research and development to introduce new and more effective vaccines, improve vaccine delivery methods, and expand their geographical reach through strategic partnerships and acquisitions. For instance, Zoetis's acquisition of Fish Vet Group has strengthened its position in the market by enhancing its diagnostic capabilities and vaccine offerings. Additionally, collaboration between companies and academic institutions is prevalent, aiming to advance vaccine technology and address emerging fish diseases. For instance, in March 2023, Indian Immunologicals (IIL) partnered with the Central Institute of Freshwater Aquaculture (CIFA) for the commercial development of a vaccine against hemorrhagic septicemia in freshwater fish. Furthermore, smaller, regional players also contribute to the market by catering to specific local needs and regulatory requirements.

Recent Developments:

In November 2022, Indian Immunologicals (IIL) planned to launch a fish vaccine, marking its entry into the aquaculture market. The vaccine will be developed in partnership with the Central Institute of Fisheries Education (CIFE) for bacterial diseases in freshwater fish, such as Columnaris Disease and Edwardsiellosis.

In May 2024, HIPRA, announced the launch of ICTHIOVAC VNN, an inactivated vaccine against Viral Nervous Necrosis (VNN) in sea bass, in the Mediterranean region. This vaccine is designed to protect sea bass against VNN, a significant disease affecting the aquaculture industry in the region

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FISH VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Aleph Farms

BioMar Group

Ceva Sante Animale

Elanco Animal Health (part of Eli Lilly and Company)

Fish Vet Group (part of Benchmark Holdings plc)

HIPRA

Hipra Animal Health Limited

Intervet Inc. (part of Merck & Co., Inc.)

Merck Animal Health (part of Merck & Co., Inc.)

MSD Animal Health (part of Merck & Co., Inc.)

Nisseiken Co., Ltd.

Syndel Laboratories

Vaxxinova

Vetech Laboratories

Vetoquinol S.A.

Zoetis Inc.

Others

GLOBAL FISH VACCINES MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Killed Vaccine
  • Inactivated Vaccine
  • Attenuated Vaccine
  • Toxoid Vaccine
  • Subunit Vaccine
  • Conjugate Vaccine
  • Recombinant Vector Vaccines

GLOBAL FISH VACCINES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Furunculosis
  • Vibriosis
  • Yersiniosis
  • Enteric septicaemia
  • Others

GLOBAL FISH VACCINES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Injection
  • Immersion
  • Spray
  • Oral

GLOBAL FISH VACCINES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Aquaculture Farms
  • Hatcheries
  • Research Institutes

GLOBAL FISH VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Fish Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Fish Vaccines Market Snippet by Vaccine Type
    • 2.1.2. Fish Vaccines Market Snippet by Indication
    • 2.1.3. Fish Vaccines Market Snippet by Route of Administration
    • 2.1.4. Fish Vaccines Market Snippet by End-User
    • 2.1.5. Fish Vaccines Market Snippet by Country
    • 2.1.6. Fish Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. Fish Vaccines Key Market Trends

  • 3.1. Fish Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Fish Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Fish Vaccines Market Opportunities
  • 3.4. Fish Vaccines Market Future Trends

4. Fish Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Fish Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Fish Vaccines Market Landscape

  • 6.1. Fish Vaccines Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Fish Vaccines Market - By Vaccine Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vaccine Type, 2023 & 2032 (%)
    • 7.1.2. Killed Vaccine
    • 7.1.3. Inactivated Vaccine
    • 7.1.4. Attenuated Vaccine
    • 7.1.5. Toxoid Vaccine
    • 7.1.6. Subunit Vaccine
    • 7.1.7. Conjugate Vaccine
    • 7.1.8. Recombinant Vector Vaccines

8. Fish Vaccines Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 8.1.2. Furunculosis
    • 8.1.3. Vibriosis
    • 8.1.4. Yersiniosis
    • 8.1.5. Enteric septicaemia
    • 8.1.6. Others

9. Fish Vaccines Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 9.1.2. Injection
    • 9.1.3. Immersion
    • 9.1.4. Spray
    • 9.1.5. Oral

10. Fish Vaccines Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Aquaculture Farms
    • 10.1.3. Hatcheries
    • 10.1.4. Research Institutes

11. Fish Vaccines Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Fish Vaccines Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Fish Vaccines Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Fish Vaccines Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Fish Vaccines Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Fish Vaccines Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Fish Vaccines Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Aleph Farms
    • 12.2.2. BioMar Group
    • 12.2.3. Ceva Sante Animale
    • 12.2.4. Elanco Animal Health (part of Eli Lilly and Company)
    • 12.2.5. Fish Vet Group (part of Benchmark Holdings plc)
    • 12.2.6. HIPRA
    • 12.2.7. Hipra Animal Health Limited
    • 12.2.8. Intervet Inc. (part of Merck & Co., Inc.)
    • 12.2.9. Merck Animal Health (part of Merck & Co., Inc.)
    • 12.2.10. MSD Animal Health (part of Merck & Co., Inc.)
    • 12.2.11. Nisseiken Co., Ltd.
    • 12.2.12. Syndel Laboratories
    • 12.2.13. Vaxxinova
    • 12.2.14. Vetech Laboratories
    • 12.2.15. Vetoquinol S.A.
    • 12.2.16. Zoetis Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us